24
panel
Pain Points and Potential for Cell and Gene Therapies
Cell and gene therapies have the potential to transform the lives of patients and their families
. As judged by patients' perspectives and experiences, how close are we to realizing this potential?
+ Read More
panel
New Pathways to Neuroscience Breakthroughs
Brain-based illnesses and injuries are the leading cause of disability worldwide. However, medic
al professionals lack the tools needed to diagnose and treat illnesses ranging from Alzheimer's disease to post-traumatic stress disorder (PTSD).
+ Read More
panel
Brain Health: Turning Scientific Discovery into Action (Invite only)
The brain is the most important organ in the body, generating every thought, sensation, memory,
emotion, and movement. Yet we rarely focus specifically on caring for the brain and generally do not monitor changes in brain health and function over time.
+ Read More
panel
Reducing the Cost and Risk of Dementia
The Milken Institute projects that over the next 20 years, the prevalence of dementia in the US
will double from nearly 7.2 million to nearly 13 million, with women comprising about two-thirds of those expected to develop dementia.
+ Read More
panel
Resilient Communities, Successful Disaster Recovery
A panel of disaster-recovery experts and philanthropists will discuss how they can work together
to build community resilience in order to help communities recover more successfully and quickly.
+ Read More
panel
Age-Forward 2030: The Intersection of Housing and Health Care
Affordable housing and connected health services are the two most critical policy interventions
that local leaders need to prioritize before 2030 as they prepare for aging populations, according to a forthcoming Milken Institute survey.
+ Read More
panel
Housing for Health: The Future of Age-Forward Communities (Invite only)
Affordable housing and connected health services are the two most critical policy interventions
that local leaders will need to prioritize before 2030 as they prepare for population aging, according to a forthcoming Milken Institute survey.
+ Read More
panel
Achieving More Person-Centered Prevention and Treatment of Chronic Diseases
Life expectancy in the US declined by 1.5 years from 2019 to 2020 in the largest 1-year drop sin
ce World War II. While COVID-19 caused 74 percent of the decline, chronic conditions such as diabetes, heart disease, and kidney disease take a heavy toll.
+ Read More
panel
Using Patient Data in Research: Balancing Benefits and Risks
We are capturing, tracking, and creating more data than ever about our lifestyle and health. Mor
e and more companies hold our data, which we sign away by indicating that we've read extensive privacy policies, when few of us actually have.
+ Read More
panel
Opioid Addiction: A Crisis Fueled by Stigma
Many of us are fortunate to live in a country with unparalleled access to scientific advances an
d medical treatments, where patients travel from all over the world to receive cutting-edge, lifesaving medical care.
+ Read More
panel
Is Digital Health a Bridge to Health Equity and Representation?
Systemic health-care inequities exposed by the COVID-19 pandemic included minority under-represe
ntation in research and disparities in care.
+ Read More
panel
The Silent Patient at Work: How Employers Are Doing More for Substance Use Disorders and Mental Health
The CDC reported a record 93,000 overdose deaths in the US in 2020. Though addiction may yield t
o COVID-19 in the news, this grim number tells that the addiction crisis rages on, exacerbated by the effects of necessary social distancing measures.
+ Read More